These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
176 related articles for article (PubMed ID: 10405124)
1. Hyperacute changes in glucose metabolism of brain tumors after stereotactic radiosurgery: a PET study. Maruyama I; Sadato N; Waki A; Tsuchida T; Yoshida M; Fujibayashi Y; Ishii Y; Kubota T; Yonekura Y J Nucl Med; 1999 Jul; 40(7):1085-90. PubMed ID: 10405124 [TBL] [Abstract][Full Text] [Related]
2. Acute effects of stereotactic radiosurgery on the kinetics of glucose metabolism in metastatic brain tumors: FDG PET study. Yamamoto T; Nishizawa S; Maruyama I; Yoshida M; Tsuchida T; Waki A; Fujibayashi Y; Kubota T; Yonekura Y; Itoh H Ann Nucl Med; 2001 Apr; 15(2):103-9. PubMed ID: 11448067 [TBL] [Abstract][Full Text] [Related]
3. Regional methionine and glucose uptake in high-grade gliomas: a comparative study on PET-guided stereotactic biopsy. Goldman S; Levivier M; Pirotte B; Brucher JM; Wikler D; Damhaut P; Dethy S; Brotchi J; Hildebrand J J Nucl Med; 1997 Sep; 38(9):1459-62. PubMed ID: 9293808 [TBL] [Abstract][Full Text] [Related]
4. Brain metastases after stereotactic radiosurgery using the Leksell gamma knife: can FDG PET help to differentiate radionecrosis from tumour progression? Belohlávek O; Simonová G; Kantorová I; Novotný J; Liscák R Eur J Nucl Med Mol Imaging; 2003 Jan; 30(1):96-100. PubMed ID: 12483415 [TBL] [Abstract][Full Text] [Related]
6. Preoperative evaluation of 54 gliomas by PET with fluorine-18-fluorodeoxyglucose and/or carbon-11-methionine. Kaschten B; Stevenaert A; Sadzot B; Deprez M; Degueldre C; Del Fiore G; Luxen A; Reznik M J Nucl Med; 1998 May; 39(5):778-85. PubMed ID: 9591574 [TBL] [Abstract][Full Text] [Related]
7. Independent thallium-201 accumulation and fluorine-18-fluorodeoxyglucose metabolism in glioma. Oriuchi N; Tomiyoshi K; Inoue T; Ahmad K; Sarwar M; Tokunaga M; Suzuki H; Watanabe N; Hirano T; Horikoshi S; Shibasaki T; Tamura M; Endo K J Nucl Med; 1996 Mar; 37(3):457-62. PubMed ID: 8772644 [TBL] [Abstract][Full Text] [Related]
8. Glucose metabolism in human malignant gliomas measured quantitatively with PET, 1-[C-11]glucose and FDG: analysis of the FDG lumped constant. Spence AM; Muzi M; Graham MM; O'Sullivan F; Krohn KA; Link JM; Lewellen TK; Lewellen B; Freeman SD; Berger MS; Ojemann GA J Nucl Med; 1998 Mar; 39(3):440-8. PubMed ID: 9529289 [TBL] [Abstract][Full Text] [Related]
9. Use of stereotactic PET images in dosimetry planning of radiosurgery for brain tumors: clinical experience and proposed classification. Levivier M; Massager N; Wikler D; Lorenzoni J; Ruiz S; Devriendt D; David P; Desmedt F; Simon S; Van Houtte P; Brotchi J; Goldman S J Nucl Med; 2004 Jul; 45(7):1146-54. PubMed ID: 15235060 [TBL] [Abstract][Full Text] [Related]
10. Use of [18F]fluorodeoxyglucose positron emission tomography in patients with primary malignant brain tumors. Janus TJ; Kim EE; Tilbury R; Bruner JM; Yung WK Ann Neurol; 1993 May; 33(5):540-8. PubMed ID: 8498831 [TBL] [Abstract][Full Text] [Related]
11. 1-11C-acetate versus 18F-FDG PET in detection of meningioma and monitoring the effect of gamma-knife radiosurgery. Liu RS; Chang CP; Guo WY; Pan DH; Ho DM; Chang CW; Yang BH; Wu LC; Yeh SH J Nucl Med; 2010 Jun; 51(6):883-91. PubMed ID: 20484430 [TBL] [Abstract][Full Text] [Related]
12. Increased fluorine-18 2-fluoro-2-deoxy-D-glucose (FDG) uptake in childhood CNS tumors is correlated with malignancy grade: a study with FDG positron emission tomography/magnetic resonance imaging coregistration and image fusion. Borgwardt L; Højgaard L; Carstensen H; Laursen H; Nowak M; Thomsen C; Schmiegelow K J Clin Oncol; 2005 May; 23(13):3030-7. PubMed ID: 15860860 [TBL] [Abstract][Full Text] [Related]
13. Recurrent tumor vs radiation effects after gamma knife radiosurgery of intracerebral metastases: diagnosis with PET-FDG. Mogard J; Kihlström L; Ericson K; Karlsson B; Guo WY; Stone-Elander S J Comput Assist Tomogr; 1994; 18(2):177-81. PubMed ID: 8126264 [TBL] [Abstract][Full Text] [Related]
14. Although Non-diagnostic Between Necrosis and Recurrence, FDG PET/CT Assists Management of Brain Tumours After Radiosurgery. Torrens M; Malamitsi J; Karaiskos P; Valotassiou V; Laspas F; Andreou J; Stergiou C; Prassopoulos V In Vivo; 2016; 30(4):513-20. PubMed ID: 27381617 [TBL] [Abstract][Full Text] [Related]
15. Identification of early recurrence of primary central nervous system tumors by [18F]fluorodeoxyglucose positron emission tomography. Glantz MJ; Hoffman JM; Coleman RE; Friedman AH; Hanson MW; Burger PC; Herndon JE; Meisler WJ; Schold SC Ann Neurol; 1991 Apr; 29(4):347-55. PubMed ID: 1929205 [TBL] [Abstract][Full Text] [Related]
16. Irradiation effects on the metabolism of metastatic brain tumors: analysis by positron emission tomography and 1H-magnetic resonance spectroscopy. Yoshino E; Ohmori Y; Imahori Y; Higuchi T; Furuya S; Naruse S; Mori T; Suzuki K; Yamaki T; Ueda S; Tsuzuki T; Takai S Stereotact Funct Neurosurg; 1996; 66 Suppl 1():240-59. PubMed ID: 9032867 [TBL] [Abstract][Full Text] [Related]
17. Decreased cerebral glucose metabolism in patients with brain tumors: an effect of corticosteroids. Fulham MJ; Brunetti A; Aloj L; Raman R; Dwyer AJ; Di Chiro G J Neurosurg; 1995 Oct; 83(4):657-64. PubMed ID: 7674016 [TBL] [Abstract][Full Text] [Related]
18. Fluorine-18-FDG PET and iodine-123-IMT SPECT in the evaluation of brain tumors. Weber W; Bartenstein P; Gross MW; Kinzel D; Daschner H; Feldmann HJ; Reidel G; Ziegler SI; Lumenta C; Molls M; Schwaiger M J Nucl Med; 1997 May; 38(5):802-8. PubMed ID: 9170450 [TBL] [Abstract][Full Text] [Related]